Clinical Trials Logo

Clinical Trial Summary

The incidence of stone disease of the urinary tract in children is increasingly increasing with a remarkable economic impact for its management. This incidence is variable according to race, geographic region, socio-economic status and dietary habits. Oxalo-calcium stones are the most common but the biochemical nature of urinary stones varies depending on the region where those of a phosphatic nature are characterized by a higher incidence in Europe. The diagnosis is confirmed by imaging. The unprepared abdomen (ASP) has low diagnostic accuracy. The scanner is the reference tool but remains an irradiating examination. Risk factors for disease recurrence include primarily the presence of an underlying urinary metabolic abnormality and young age. Urinary metabolic abnormalities vary from one study to another. The understanding of lithogenesis, its evaluation as well as the therapeutic options is essential for adequate and adapted management in the pediatric population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06032364
Study type Observational
Source University Hospital, Strasbourg, France
Contact Isabelle TALON, MD
Phone 33 3 88 12 72 96
Email Isabelle.TALON@chru-strasbourg.fr
Status Recruiting
Phase
Start date August 23, 2023
Completion date August 23, 2024

See also
  Status Clinical Trial Phase
Completed NCT06357052 - The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Completed NCT03111381 - Toradol to Reduce Ureteroscopic Symptoms Trial Phase 2
Completed NCT01589484 - Impact of Renal Anatomy on Shock Wave Lithotripsy Outcomes for Lower Pole Kidney Stones N/A